Information about current studies recruiting patients:
Principal investigator:
Atilla Ertan, MD
Currently recruiting for Crohn's Disease, Ulcerative Colitis, and IBS Patients for Clinical Trials. For more infomration, contact Clinical Research Coordinators:
Inci E. Ertan, PhD or Dora L. Hawkinson, PA-C
713-500-6457 ph 713-704-3485 fx
Dora.L.Hawkinson@uth.tmc.edu
Location:
64000 Fannin Street, Suite 1400; Houston, Texas 77030 United States
Abbott Active
“A 5-Year, National Registry Study of Humira® (Adalimumab) in Patients with Moderately to Severely Active Crohn's Disease (CD)”
Barrx Protocol Active
“HALO Patient National Registry: Ablation of Barrett's Esophagus”
UCB Protocol Active
“SECURE”: A Non-Interventional Long-term Post-Marketing Registry of Patients Treated with Certolizumab Pegol (Cimzia®) for Crohn's Disease”
Centocor Protocol Active
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Subjects with Moderately to Severely Active Crohn’s Disease”
Centocor Protocol Active
“A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Subjects with Moderately to Severely Active Crohn’s Disease”.
How to Volunteer for a Clinical Trial